1Packer M. The neurohormonal hypothesis:A theory to the mechanism of disease progression in heart failure[J]. J Am Coll Cardiol, 1992,20( 1 ) : 248-254.
2Kiowski W, Sutsch G, Hunziker P, et al. Evidence for endotholine-1-mediated vasoconstriction in severe chronic heart failure [ J ]. Lancet,1995,346(8976) :732-736.
3Pettetta M, Condorelli GL, Spinelli L, et al. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure[ J]. Am Heart J,2000,140[ Suppl ] : E28.
4Kapadia S, Dibba Z, Kurrelmeyer K, et al. The role of cytokines in the failing human heart[J]. Cardiol Clin, 1998,16(4) :645-656.
5Chen HH, Burner JC. The natriuretic peptides in heart failure:Diagnosis and therapeutic potentials[J] .Proc Assoc Am Physicians, 1999,111(5) :406-416.
6Hobbs RE, Mills RM. Therapeutic potential of nesiritide ( recombinant B-type natriuretic peptide) in the treatment of heart failure[J]. Expert Opin Investig Drugs, 1999,8(6) : 1063-1072.
7Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic,neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure[J] .J Card Fail, 1998,4( 1 ):37-44.
8Mills RM, Lejemtel TH, Horton DP, et al. Sustained hemodenamic effects of an infusion of nesiritide (human B-type natriuretic peptide) in heart failure. A randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group[ J ] . J Am Coll Cardial, 1999,34 ( 1 ) : 155-162.
9Abreaham WT, Johnson AD, Wagoner L, et al. Nesiritide( human B-type natriuretic peptide) improves symptoms and hemodynamics in NYHA Class Ⅲ and Ⅳ heart failure[J] .J Am Coll Cardiol, 1999,33[ Suppl ii] : 188A.
10Collucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group[ H ]. N Engl Med, 2000,343 (4) : 246-253.
7[1]K one BC M olecular biology of natrinretic PePtides and nitricox ide synthases[J]Card:o.a、 c Re,2001,51(3):439～441.
8[3]Waku S,lidia N,Ishihara T.Significance of brain natriuretic peptide measurement as a diagnostic indicator of cardiac function.[J]Methods Inf Med,2000,39(3):249～253.
9[4]Maisel S,Jen K,Padina K,et al.Utility of B-natriuretic peptide as a rapid point-of-care test for screering patients undergoing echocardiolography to determine left ventricular dyfunction.[J]Aim heart,2001,141(3):267～374.
10[7]Falcao,-L-M.Pinto,-F.Ravara,-L.BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.[J]J-Renin-Angiotensin-Aldosterone-Syst.,2004,95(3):121 ～129.
